FI952926A - Menetelmät allergioiden hoitamiseksi tai ehkäisemiseksi - Google Patents

Menetelmät allergioiden hoitamiseksi tai ehkäisemiseksi Download PDF

Info

Publication number
FI952926A
FI952926A FI952926A FI952926A FI952926A FI 952926 A FI952926 A FI 952926A FI 952926 A FI952926 A FI 952926A FI 952926 A FI952926 A FI 952926A FI 952926 A FI952926 A FI 952926A
Authority
FI
Finland
Prior art keywords
treating
methods
preventing allergies
allergies
preventing
Prior art date
Application number
FI952926A
Other languages
English (en)
Swedish (sv)
Other versions
FI952926A0 (fi
FI104465B (fi
Inventor
Erika Isolauri
Leena Metsaeniitty
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaeoja
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI952926(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Priority to FI952926A priority Critical patent/FI104465B/fi
Publication of FI952926A0 publication Critical patent/FI952926A0/fi
Priority to MYPI96002357A priority patent/MY113912A/en
Priority to US08/973,963 priority patent/US6506380B1/en
Priority to CZ19973997A priority patent/CZ291904B6/cs
Priority to RO97-02328A priority patent/RO120243B1/ro
Priority to AT96918707T priority patent/ATE230606T1/de
Priority to PL96324010A priority patent/PL185123B1/pl
Priority to EE9700339A priority patent/EE03424B1/xx
Priority to KR1019970709383A priority patent/KR100494741B1/ko
Priority to CNB961947527A priority patent/CN1154506C/zh
Priority to SK1715-97A priority patent/SK284245B6/sk
Priority to DK96918707T priority patent/DK0833649T4/da
Priority to NZ310478A priority patent/NZ310478A/xx
Priority to DE69625690T priority patent/DE69625690T3/de
Priority to CA2224320A priority patent/CA2224320C/en
Priority to BR9607827-8A priority patent/BR9607827A/pt
Priority to AU61278/96A priority patent/AU710126C/en
Priority to JP50267197A priority patent/JP3983804B2/ja
Priority to PCT/FI1996/000350 priority patent/WO1997000078A1/en
Priority to EP96918707A priority patent/EP0833649B2/en
Priority to IL12257796A priority patent/IL122577A0/xx
Priority to ES96918707T priority patent/ES2191103T5/es
Priority to ARP960103134A priority patent/AR003960A1/es
Priority to ZA965088A priority patent/ZA965088B/xx
Publication of FI952926A publication Critical patent/FI952926A/fi
Priority to MX9710109A priority patent/MX9710109A/es
Priority to NO19975832A priority patent/NO321504B1/no
Priority to BG102144A priority patent/BG63153B1/bg
Priority to HK98110938A priority patent/HK1010081A1/xx
Publication of FI104465B publication Critical patent/FI104465B/fi
Application granted granted Critical
Priority to US10/321,661 priority patent/US7172756B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI952926A 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö FI104465B (fi)

Priority Applications (29)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
MYPI96002357A MY113912A (en) 1995-06-14 1996-06-11 Method of preventing or treating allergies
ES96918707T ES2191103T5 (es) 1995-06-14 1996-06-12 Procedimientos de prevencion o de tratamiento de alergia.
DE69625690T DE69625690T3 (de) 1995-06-14 1996-06-12 Verfahren zur vorbeugung und behandlung von allergien
JP50267197A JP3983804B2 (ja) 1995-06-14 1996-06-12 アレルギーを予防または治療する方法
RO97-02328A RO120243B1 (ro) 1995-06-14 1996-06-12 Procedee de preparare a unor formule de hidrolizat proteic, pentru prevenirea sau tratarea alergiilor şi utilizarea acestora
AT96918707T ATE230606T1 (de) 1995-06-14 1996-06-12 Verfahren zur vorbeugung und behandlung von allergien
PL96324010A PL185123B1 (pl) 1995-06-14 1996-06-12 Sposób wytwarzania mieszanki hydrolizatu białkowego i zastosowanie mieszanki hydrolizatu białkowego
EE9700339A EE03424B1 (et) 1995-06-14 1996-06-12 Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod
KR1019970709383A KR100494741B1 (ko) 1995-06-14 1996-06-12 알레르기의치료또는예방방법
CNB961947527A CN1154506C (zh) 1995-06-14 1996-06-12 预防或治疗过敏的方法
SK1715-97A SK284245B6 (sk) 1995-06-14 1996-06-12 Spôsob výroby proteínového hydrolyzátového prostriedku a jeho použitie
DK96918707T DK0833649T4 (da) 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier
NZ310478A NZ310478A (en) 1995-06-14 1996-06-12 method of making a protein hydrolysate formulation derived by hydrolysing proteins with enzymes from a probiotic gastointestinal bacteria and with pepsin and/or trypsin
US08/973,963 US6506380B1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
CA2224320A CA2224320C (en) 1995-06-14 1996-06-12 Method of promoting hypoallergenicity or tolerogenic immune response and compositions therefor
BR9607827-8A BR9607827A (pt) 1995-06-14 1996-06-12 Método para fazer uma fórmula de hidrolisado de proteìna, fórmula de hidrolizado de proteìna,métodos de prevenir ou tratar reações de hipersensibilidade induzidas por alimentos, de tratar alergia a leite de vaca e de promoves respostas tolerogênicas imunes a antìgenos de alimentos.
AU61278/96A AU710126C (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
CZ19973997A CZ291904B6 (cs) 1995-06-14 1996-06-12 Způsob výroby proteinového hydrolyzátového prostředku, tento prostředek a jeho použití
PCT/FI1996/000350 WO1997000078A1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
EP96918707A EP0833649B2 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
IL12257796A IL122577A0 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
ARP960103134A AR003960A1 (es) 1995-06-14 1996-06-13 Metodo y medios para suprimir reacciones de hipersensibilidad inducidas por alimentos en pacientes que sufren de alergia a los alimentos
ZA965088A ZA965088B (en) 1995-06-14 1996-06-14 Methods of preventing or treating allergles
MX9710109A MX9710109A (es) 1995-06-14 1997-12-11 Metodo y medios para suprimir reacciones de hipersensibilidad inducidas por alimentos en pacientes que sufren de alergia a los alimentos.
NO19975832A NO321504B1 (no) 1995-06-14 1997-12-11 Fremgangsmater for in vitro fremstilling av proteinhydrolysatsammensetning, oral proteinhydrolysatsammensetning og anvendelser derav.
BG102144A BG63153B1 (bg) 1995-06-14 1997-12-23 Метод за получаване на протеинов хидролизат и използването му за предотвратяване или лечение на алергии
HK98110938A HK1010081A1 (en) 1995-06-14 1998-09-24 Methods of preventing or treating allergies
US10/321,661 US7172756B2 (en) 1995-06-14 2002-12-18 Methods of promoting tolerogenic immune responses and compositions therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926 1995-06-14
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Publications (3)

Publication Number Publication Date
FI952926A0 FI952926A0 (fi) 1995-06-14
FI952926A true FI952926A (fi) 1996-12-15
FI104465B FI104465B (fi) 2000-02-15

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Country Status (27)

Country Link
US (2) US6506380B1 (fi)
EP (1) EP0833649B2 (fi)
JP (1) JP3983804B2 (fi)
KR (1) KR100494741B1 (fi)
CN (1) CN1154506C (fi)
AR (1) AR003960A1 (fi)
AT (1) ATE230606T1 (fi)
BG (1) BG63153B1 (fi)
BR (1) BR9607827A (fi)
CA (1) CA2224320C (fi)
CZ (1) CZ291904B6 (fi)
DE (1) DE69625690T3 (fi)
DK (1) DK0833649T4 (fi)
EE (1) EE03424B1 (fi)
ES (1) ES2191103T5 (fi)
FI (1) FI104465B (fi)
HK (1) HK1010081A1 (fi)
IL (1) IL122577A0 (fi)
MX (1) MX9710109A (fi)
MY (1) MY113912A (fi)
NO (1) NO321504B1 (fi)
NZ (1) NZ310478A (fi)
PL (1) PL185123B1 (fi)
RO (1) RO120243B1 (fi)
SK (1) SK284245B6 (fi)
WO (1) WO1997000078A1 (fi)
ZA (1) ZA965088B (fi)

Families Citing this family (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0986314B1 (en) * 1997-06-03 2008-09-10 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with sids
EP1072010B1 (en) 1999-01-19 2010-04-21 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
TR200200300T2 (tr) 1999-08-05 2003-03-21 Societe Des Produits Nestle S.A. İshali önlemeye elverişli bifidobakteriler.
ES2321797T3 (es) 1999-08-05 2009-06-12 Societe Des Produits Nestle S.A. Bifidobacterias que previenen la diarrea causada por bacterias patogenicas.
US20020031787A1 (en) * 2000-02-04 2002-03-14 Maclaren Noel K. Compositions and methods for reducing autoimmunity
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
RU2294366C2 (ru) * 2000-09-25 2007-02-27 Сосьете Де Продюи Нестле С.А. Трансформированные молочно-кислые бактерии, снижающие склонность к проявлению аллергических реакций, и их применение
AU2002220587B2 (en) 2000-10-06 2006-06-29 Societe Des Produits Nestle S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
JP2004519241A (ja) * 2001-03-09 2004-07-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 高齢化に伴う生理的障害を改善し寿命を延ばす組成物
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
AU2003236689A1 (en) 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
EP1565547B2 (en) 2002-06-28 2012-09-19 Biosearch S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ES2416287T3 (es) 2003-06-23 2013-07-31 Nestec S.A. Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal
AU2005216528B2 (en) 2004-02-25 2009-06-04 Pioneer Hi-Bred International, Inc. Novel Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
MX2007012697A (es) 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
RU2440129C2 (ru) * 2005-11-14 2012-01-20 Нестек С.А. Стимулирование пероральной толерантности гликозилированными белками
PL1986669T3 (pl) 2006-02-15 2012-09-28 Nestec Sa Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
BRPI0708689A2 (pt) 2006-03-07 2011-06-07 Nestec Sa mistura simbiótica
CN101460067B (zh) * 2006-06-15 2012-09-26 雀巢产品技术援助有限公司 诱导对卵蛋白的耐受
ATE544457T1 (de) * 2007-02-28 2012-02-15 Mead Johnson Nutrition Co Verfahren zur behandlung bzw. prävention systemischer entzündungen
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1974734A1 (en) † 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
WO2009029554A2 (en) 2007-08-24 2009-03-05 Codexis, Inc. Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
JP2011509677A (ja) 2008-01-24 2011-03-31 ネステク ソシエテ アノニム 栄養原料を含むカプセル、及び、カプセルから栄養液体を送出する方法
LT2244734T (lt) 2008-02-01 2016-09-12 Murdoch Childrens Research Institute Alergeno toleravimo paskatinimo būdas
SG188887A1 (en) 2008-03-14 2013-04-30 Nestec Sa Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
ES2705694T3 (es) 2008-06-13 2019-03-26 Codexis Inc Método de síntesis de variantes de polinucleótidos
MX2010014500A (es) 2008-06-24 2011-05-30 Codexis Inc Procedimientos biocataliticos para la preparacion de compuestos de prolina biciclica fusionada sustancialmente estereomericamente puros.
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
HUE026181T2 (en) 2008-08-27 2016-05-30 Codexis Inc Ketoreductase polypeptide for the preparation of 3-aryl-3-hydroxypropanamine from 3-aryl-3-ketopropanamine
DK2385983T3 (en) 2009-01-08 2018-02-12 Codexis Inc Transaminase POLYPEPTIDES
WO2010107644A2 (en) 2009-03-17 2010-09-23 Codexis, Inc. Variant endoglucanases and related polynucleotides
US8088608B2 (en) 2009-03-31 2012-01-03 Codexis, Inc. Endoglucanases
EP2443139B1 (en) 2009-06-16 2016-08-10 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
US8796002B2 (en) 2009-06-22 2014-08-05 Codexis, Inc. Polypeptides for a ketoreductase-mediated stereoselective route to alpha chloroalcohols
US8614081B2 (en) 2009-07-23 2013-12-24 Codexis, Inc. Nitrilase biocatalysts
SG178167A1 (en) * 2009-08-18 2012-03-29 Nestec Sa A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
PL2467031T3 (pl) 2009-08-18 2015-03-31 Nestec Sa Odżywcza kompozycja zawierająca szczepy lactococcus i zmniejszająca objawy alergiczne, zwłaszcza dla małych dzieci i dzieci
SG10201405022PA (en) 2009-08-19 2014-10-30 Codexis Inc Ketoreductase polypeptides for the preparation of phenylephrine
WO2011028708A1 (en) 2009-09-04 2011-03-10 Codexis, Inc. Variant cbh2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
HUE051913T2 (hu) 2009-09-18 2021-04-28 Codexis Inc Csökkentett kodon mutagenezis
CN102666848B (zh) 2009-11-25 2014-09-24 科德克希思公司 用于从纤维素生物质产生可发酵的糖的重组嗜热子囊菌β-葡糖苷酶变体
MX2012006016A (es) 2009-11-25 2012-06-25 Codexis Inc Variantes de beta-glucosidasa recombinante para produccion de azucares solubles de biomasa celulosica.
CN102884178B (zh) 2009-12-08 2014-12-03 科德克希思公司 拉唑化合物的合成
WO2011069987A1 (en) 2009-12-08 2011-06-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
WO2011082304A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
EP2566497B1 (en) 2010-05-04 2015-07-29 Codexis, Inc. Biocatalysts for ezetimibe synthesis
EP2569331A1 (en) 2010-05-10 2013-03-20 Perseid Therapeutics LLC Polypeptide inhibitors of vla4
EP2576804B1 (en) 2010-05-28 2016-12-14 Codexis, Inc. Pentose fermentation by a recombinant microorganism
WO2011159910A2 (en) 2010-06-17 2011-12-22 Codexis, Inc. Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol
BR112012033361A2 (pt) 2010-06-28 2020-10-20 Codexis, Inc. acul-redutases formadoras de álcoois graxos (fars) e seus modos de uso.
AU2011272878B2 (en) 2010-06-30 2015-04-23 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
EP2605772B1 (en) 2010-08-16 2016-06-22 Cardiome International AG Process for preparing aminocyclohexyl ether compounds
CN103080306B (zh) 2010-08-20 2015-02-18 科德克希思公司 糖苷水解酶61家族蛋白在纤维素加工中的用途
WO2012078800A2 (en) 2010-12-08 2012-06-14 Codexis, Inc. Biocatalysts and methods for the synthesis of armodafinil
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
WO2012135110A1 (en) 2011-03-30 2012-10-04 Codexis, Inc. Pentose fermentation by a recombinant microorganism
DK2697662T3 (en) 2011-04-13 2018-07-30 Codexis Inc BIOCATALYTIC PROCEDURE FOR PREPARING ESLICARBAZEPIN AND ANALOGUES THEREOF
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
US8778652B2 (en) 2011-06-30 2014-07-15 Codexis, Inc. Pentose fermentation by a recombinant microorganism
WO2013028701A1 (en) 2011-08-22 2013-02-28 Codexis, Inc. Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity
US9109209B2 (en) 2011-09-08 2015-08-18 Codexis, Inc. Biocatalysts and methods for the synthesis of substituted lactams
US20130084608A1 (en) 2011-09-30 2013-04-04 Codexis, Inc. Fungal proteases
US20130084271A1 (en) * 2011-10-03 2013-04-04 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
SG11201402401TA (en) 2011-11-18 2014-06-27 Codexis Inc Biocatalysts for the preparation of hydroxy substituted carbamates
EP2794871A4 (en) 2011-12-20 2015-12-30 Codexis Inc VARIANTS OF ENDOGLUCANASE-1B (EG1B)
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
SG11201405990PA (en) 2012-03-23 2014-11-27 Codexis Inc Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
HUE042605T2 (hu) 2012-05-08 2019-07-29 Codexis Inc Biokatalizátorok és kémiai vegyületek hidroxilálására szolgáló eljárások
HUE036947T2 (hu) 2012-05-11 2018-08-28 Codexis Inc Átalakított iminreduktázok és eljárások keton- és aminvegyületek reduktív aminálására
WO2013188305A2 (en) 2012-06-11 2013-12-19 Codexis, Inc. Fungal beta-xylosidase variants
EP2922953A4 (en) 2012-11-20 2016-11-09 Shell Int Research FERMENTATION OF PENTOSIS BY A RECOMBINANT MICROORGANISM
WO2014088984A1 (en) 2012-12-07 2014-06-12 Merck Sharp & Dohme Corp. Biocatalytic transamination process
JP6618180B2 (ja) 2012-12-21 2019-12-11 コデクシス， インコーポレイテッド キラルアミンを合成するための操作された生体触媒および方法
EP2946006B1 (en) 2013-01-18 2019-04-10 Codexis, Inc. Engineered biocatalysts useful for carbapenem synthesis
CN115927231A (zh) 2013-02-28 2023-04-07 科德克希思公司 用于工业生物催化的工程化转氨酶多肽
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
RS58802B1 (sr) 2013-04-18 2019-07-31 Codexis Inc Modifikovani fenilalanin-amonijak-liazni polipeptidi
CN106232619B (zh) 2013-11-13 2022-09-09 科德克希思公司 工程化的亚胺还原酶和用于酮和胺化合物的还原胺化的方法
EP3145536B1 (en) 2014-04-16 2021-10-27 Codexis, Inc. Engineered tyrosine ammonia lyase
DK3167052T3 (da) 2014-07-09 2020-02-10 Codexis Inc P450-bm3-varianter med forbedret aktivitet
US10370648B2 (en) 2014-11-25 2019-08-06 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
BR112017013300A2 (pt) 2014-12-22 2018-02-27 Codexis Inc alfa galactosidase a recombinante e/ou fragmento de alfa galactosidase a recombinante biologicamente ativo, composição, sequência de polinucleotídeos recombinantes, vetor de expressão, célula hospedeira, métodos para produzir uma variante de alfa galactosidase a e para tratar e/ou prevenir os sintomas da doença de fabry, composição farmacêutica, e, uso das composições.
ES2830725T3 (es) 2015-02-10 2021-06-04 Codexis Inc Polipéptidos cetoreductasa para la síntesis de compuestos quirales
SG11201708356PA (en) 2015-05-07 2017-11-29 Codexis Inc Penicillin-g acylases
EP3319987B1 (en) 2015-07-07 2021-05-05 Codexis, Inc. Novel p450-bm3 variants with improved activity
DK3452587T3 (da) 2016-05-05 2021-10-11 Codexis Inc Penicillin-g-acylaser
CN109715817B (zh) 2016-06-09 2022-12-09 科德克希思公司 用于化合物的羟基化的生物催化剂和方法
SG11201810998WA (en) 2016-06-15 2019-01-30 Codexis Inc Engineered beta-glucosidases and glucosylation methods
US11046936B2 (en) 2016-08-26 2021-06-29 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
WO2018129130A1 (en) 2017-01-05 2018-07-12 Codexis, Inc. Penicillin-g acylases
SG11201906480QA (en) 2017-02-03 2019-08-27 Codexis Inc Engineered glycosyltransferases and steviol glycoside glucosylation methods
MX2019009615A (es) 2017-02-13 2019-10-14 Codexis Inc Polipeptidos dise?ados de fenilalanina amonio liasa.
SG11201909807TA (en) 2017-04-24 2019-11-28 Tesaro Inc Methods of manufacturing of niraparib
EP3615058A4 (en) 2017-04-27 2021-06-02 Codexis, Inc. KETOREDUCTASE-POLYPEPTIDES AND POLYNUCLEOTIDES
JP7401902B2 (ja) 2017-05-08 2023-12-20 コデクシス， インコーポレイテッド 遺伝子操作されたリガーゼバリアント
US11359183B2 (en) 2017-06-14 2022-06-14 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
JP7244089B2 (ja) 2017-06-27 2023-03-22 コデクシス， インコーポレイテッド ペニシリンｇアシラーゼ
EP3645711A4 (en) 2017-06-30 2021-04-21 Codexis, Inc. T7 RNA POLYMERASE VARIANTS
JP2020530267A (ja) 2017-06-30 2020-10-22 コデクシス， インコーポレイテッド Ｔ７ ｒｎａポリメラーゼバリアント
CN111511389A (zh) 2017-11-07 2020-08-07 科德克希思公司 转谷氨酰胺酶变体
SG11202004185PA (en) 2017-12-13 2020-06-29 Codexis Inc Carboxyesterase polypeptides for amide coupling
BR112020011881A2 (pt) 2017-12-13 2020-11-24 Glaxosmithkline Intellectual Property Development Limited biocatalisadores de carboxiesterase
CA3102968A1 (en) 2018-06-12 2019-12-19 Codexis, Inc. Engineered tyrosine ammonia lyase
WO2020014049A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered galactose oxidase variant enzymes
WO2020014047A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered purine nucleoside phosphorylase variant enzymes
JP7462969B2 (ja) 2018-07-09 2024-04-08 コデクシス， インコーポレイテッド 操作されたデオキシリボースリン酸アルドラーゼ
CN112601821A (zh) 2018-07-09 2021-04-02 科德克希思公司 工程化磷酸戊糖变位酶变体酶
MX2021000323A (es) 2018-07-09 2021-03-25 Codexis Inc Enzimas de variante de pantotenato quinasa modificadas geneticamente.
SG11202012198QA (en) 2018-07-12 2021-01-28 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
US11760981B2 (en) 2018-07-30 2023-09-19 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
EP3874033A4 (en) 2018-10-29 2022-08-03 Codexis, Inc. MANIPULATED VARIANTS OF DNA POLYMERASE
AU2019397401A1 (en) 2018-12-14 2021-06-17 Codexis, Inc. Engineered tyrosine ammonia lyase
BR112021011750A2 (pt) 2018-12-20 2021-08-31 Codexis, Inc. Alfa-galactosidase a recombinante e/ou fragmento de alfa-galactosidase a recombinante, composição, sequência de polinucleotídeo recombinante, vetor de expressão, célula hospedeira, métodos para produzir uma variante de alfa-galactosidase a e para tratar e/ou prevenir os sintomas da doença de fabry, composição farmacêutica, e, uso das composições
MX2022000903A (es) 2019-07-23 2022-02-14 Frieslandcampina Nederland Bv Composicion nutricional que comprende inmunoglobulina y grasa de la leche.
MX2022002473A (es) 2019-08-30 2022-08-02 Codexis Inc Variantes de lipasa modificadas geneticamente.
EP4027969A4 (en) 2019-09-12 2023-09-27 Codexis, Inc. PEROXIDASE ACTIVITY TOWARDS 10-ACETYL -3,7-DIHYDROXYPHENOXAZINE
EP4042149A1 (en) 2019-10-02 2022-08-17 Abbott Diabetes Care Inc. Detection of analytes by protein switches
JP2023507575A (ja) 2019-12-20 2023-02-24 コデクシス， インコーポレイテッド 操作された酸性アルファ－グルコシダーゼバリアント
IL296841A (en) 2020-04-10 2022-11-01 Codexis Inc Transaminase transaminase polypeptides
AU2021334371A1 (en) 2020-08-28 2023-03-09 Codexis, Inc. Engineered protease variants
CN116897205A (zh) 2020-08-28 2023-10-17 科德克希思公司 工程化淀粉酶变体
WO2022125960A1 (en) 2020-12-11 2022-06-16 Willow Biosciences, Inc. Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
EP4262804A2 (en) 2020-12-18 2023-10-25 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
IL305919A (en) 2021-04-02 2023-11-01 Codexis Inc A transgenic enzyme variant of adenylate kinase
EP4314262A1 (en) 2021-04-02 2024-02-07 Codexis, Inc. Engineered guanylate kinase variant enzymes
WO2022212835A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered acetate kinase variant enzymes
US20220325285A1 (en) 2021-04-02 2022-10-13 Codexis, Inc. ENGINEERED CYCLIC GMP-AMP SYNTHASE (cGAS) VARIANT ENZYMES
CA3227215A1 (en) 2021-07-30 2023-02-02 Trish Choudhary Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
CA3227236A1 (en) 2021-08-19 2023-02-23 Trish Choudhary Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
ATE84680T1 (de) † 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
DD281540A5 (de) 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
DK0421309T4 (da) † 1989-10-02 2003-04-22 Associated British Foods Plc Proteinhydrolysater
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
AU1076595A (en) 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
RO120243B1 (ro) 2005-11-30
DK0833649T3 (da) 2003-04-07
EE03424B1 (et) 2001-06-15
CZ291904B6 (cs) 2003-06-18
DK0833649T4 (da) 2009-07-20
CA2224320A1 (en) 1997-01-03
CZ399797A3 (cs) 1998-06-17
CN1154506C (zh) 2004-06-23
AU710126B2 (en) 1999-09-16
JP3983804B2 (ja) 2007-09-26
DE69625690T2 (de) 2003-11-06
SK171597A3 (en) 1998-11-04
DE69625690D1 (de) 2003-02-13
NZ310478A (en) 2000-01-28
US7172756B2 (en) 2007-02-06
NO975832D0 (no) 1997-12-11
AU6127896A (en) 1997-01-15
EE9700339A (et) 1998-06-15
IL122577A0 (en) 1998-06-15
WO1997000078A1 (en) 1997-01-03
KR19990022914A (ko) 1999-03-25
SK284245B6 (sk) 2004-12-01
DE69625690T3 (de) 2009-12-24
KR100494741B1 (ko) 2005-09-30
HK1010081A1 (en) 1999-06-11
CA2224320C (en) 2012-03-20
EP0833649B1 (en) 2003-01-08
FI952926A0 (fi) 1995-06-14
ES2191103T5 (es) 2009-11-03
EP0833649B2 (en) 2009-06-03
ZA965088B (en) 1997-01-22
FI104465B (fi) 2000-02-15
MY113912A (en) 2002-06-29
EP0833649A1 (en) 1998-04-08
ATE230606T1 (de) 2003-01-15
BG102144A (en) 1998-12-30
BR9607827A (pt) 1999-11-30
PL185123B1 (pl) 2003-02-28
US20030113340A1 (en) 2003-06-19
US6506380B1 (en) 2003-01-14
CN1187772A (zh) 1998-07-15
JPH11510791A (ja) 1999-09-21
PL324010A1 (en) 1998-04-27
BG63153B1 (bg) 2001-05-31
NO321504B1 (no) 2006-05-15
AR003960A1 (es) 1998-09-30
NO975832L (no) 1997-12-11
ES2191103T3 (es) 2003-09-01
MX9710109A (es) 1998-10-31

Similar Documents

Publication Publication Date Title
FI952926A (fi) Menetelmät allergioiden hoitamiseksi tai ehkäisemiseksi
DE69521363D1 (de) Hautalterungsschutzmittel
DE69617372D1 (de) Datenaufzeichnungs-/-wiedergabeverfahren
NO974849D0 (no) Supermartensittisk stål
PT858464E (pt) Inibidores de trombina
NO950617D0 (no) Sikkerhetssystem
DE69627579D1 (de) Personenidentifizierungssystem
DE19681419T1 (de) Behandlungssystem
NO960227L (no) Sikkerhetssystem
NO982911D0 (no) FremgangsmÕte for behandling av depresjon
BR9606678A (pt) Processo de metalurgia
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
DE69611224T2 (de) Verringerung von videomoire
ID16924A (id) Metode perlakuan poliolefin
DE69607764D1 (de) Induktives bauelement
FI973521A0 (fi) Menetelmät munasarjasyövän inhiboimiseksi
DK1593D0 (da) Emulsionsproces
BR9610514A (pt) Inibidores cicloantihelmínticos
FI102791B1 (fi) Induktiivinen komponentti
IT1268611B1 (it) Coprocessore per riconoscimento caratteri
DE69518628T2 (de) Schmuckstück
NO973629D0 (no) Sikkerhetssystem
FI964843A0 (fi) Menetelmä massan käsittelemiseksi
IT238774Y1 (it) Chiusura per monili
KR970703937A (ko) 금속단백질 분해효소 억제제(Metallproteinase inhibitors)

Legal Events

Date Code Title Description
MA Patent expired